2025 American Society of Clinical Oncology (ASCO) Annual Meeting

May 30 – Jun 3, 2025

ASCO Annual Meeting abstracts may be accessed online via https://www.asco.org/abstracts.

ASCO Poster Presentations

Saturday, May 31, 2025, 1:30pm to 4:30pm CT
Abstract #: 8644
Title: Efficacy and Safety of Pralsetinib in Patients with Advanced RET-fusion-positive NSCLC: Final Data from the Phase 1/2 ARROW Study
Presenter: Gilberto de Lima Lopes, M.D., MBA

Sunday, June 1, 2025, 9:00am to 12:00pm CT
Abstract #: 6545
Title: A Phase 2 Study of Olutasidenib in Relapsed/Refractory AML: Outcomes by Number of Prior Treatment Regimens
Presenter: Eunice S. Wang, M.D.

Abstract #: 6546
Title: Matching-adjusted Indirect Comparison (MAIC) of Olutasidenib and Ivosidenib in IDH1-mutated Relapsed/Refractory AML
Presenter: Justin M. Watts, M.D.

Monday, June 2, 2025, 1:30pm to 4:30pm CT
Abstract #: 3116
Title: Efficacy and Safety of Pralsetinib in RET Fusion-positive Solid Tumors: Final Data from the ARROW Trial
Presenter: Vivek Subbiah, M.D.